Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- CheckyesterdayChange DetectedThe page adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the label from 'Intervention / Treatment' to 'Intervention/Treatment', while also noting that recruitment is no longer ongoing and updating the revision tag to v3.6.0.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous v3.5.4. This is a minor internal version update that does not alter the study details or user-facing functionality.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a new page version. This update reflects a minor metadata change rather than a modification to study details, locations, or eligibility criteria.SummaryDifference0.0%

- Check30 days agoChange DetectedThree auxiliary sections labeled Description Related Info, AbbVie, and Helpful Links Provided by were removed, reducing footer/navigation clutter without altering the primary study details.SummaryDifference0.1%

- Check37 days agoChange DetectedThe entry for Malmö, Skåne County, Sweden, 214 28 replaces Malmo with the proper diacritic in the city name.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now displays Revision: v3.5.3 instead of Revision: v3.5.2. This indicates a minor site update that does not alter the study details or eligibility information.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.